Biodesix (BDSX) Interest Expenses (2019 - 2026)

Biodesix (BDSX) has 8 years of Interest Expenses data on file, last reported at $2.3 million in Q1 2026.

• Quarterly Interest Expenses rose 36.38% year-over-year to $2.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.3 million (down 69.0% YoY) and the FY2025 annual result came in at $106.5 million, up 7.61% from the prior year.
• Interest Expenses improved to $2.3 million in Q1 2026, from $2.1 million in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $48.3 million in Q1 2023 to a low of -$4.5 million in Q4 2022.
• A 5-year average of $12.2 million and a median of $2.5 million in 2022 frame the typical range for Interest Expenses.
• Annual changes were most pronounced in 2022 — Interest Expenses plunged 237.8% — and 2025, when it jumped 2093.33%.
• Tracing BDSX's Interest Expenses over 5 years: stood at -$4.5 million in 2022, then jumped by 239.49% to $6.3 million in 2023, then plunged by 72.17% to $1.8 million in 2024, then rose by 17.52% to $2.1 million in 2025, then rose by 11.61% to $2.3 million in 2026.
• The last three Interest Expenses figures came in at $2.3 million (Q1 2026), $2.1 million (Q4 2025), and $16.7 million (Q3 2025), per Business Quant data.